What Remilk makes and how
Remilk Ltd is an Israeli food technology company that produces real dairy proteins without keeping cattle. Its website presents the business as a maker of dairy-style foods and of the milk proteins inside them. The proteins come from microbial fermentation, a route grouped under precision fermentation, and they match the sequence of the cow protein.
The company positions its output as dairy rather than as a milk substitute. According to its own pages, the proteins are identical to those cows produce, and they are combined with vitamins, minerals, and non-animal fat and sugar. That recipe explains the claim of no cholesterol and no lactose, since both normally sit in other fractions.
For a formulator, the protein fraction is the only part made by fermentation. Everything around it is a conventional food ingredient. A reader comparing options can place the material beside precision-fermented whey and precision-fermented casein, which describe the wider class of recombinant dairy proteins and how they differ from animal-derived equivalents.
Remilk explains the process in plain terms on its science page. The team copies the gene responsible for a milk protein in cows and inserts it into yeast. The gene works as an instruction set, and the yeast then produces the protein efficiently. The page keeps to this outline and publishes no strain, titre or yield data.
The yeast is then placed in fermentors, where it multiplies quickly and makes the milk protein. The company compares this to the fermentation behind beer and sourdough. A buyer would normally expect separation, purification and drying steps before the protein reaches a recipe, though the website does not describe them, so those details belong in a supplier questionnaire.
Products and the Israeli launch
The finished foods are assembled from the recovered protein plus vitamins, minerals, plant-origin fat and sugar. Remilk reports double-blind tasting in which testers could not tell its products from conventional dairy. A developer should treat the statement as a company claim and run an independent sensory trial with a defined panel size and scoring method.
The homepage announces that products have launched to consumers. The newsroom narrows that down: in November 2025 Remilk and Gad Dairies introduced a branded product called The New Milk in Israel, described as milk without cows. Headlines in the same list point to a possible United States launch in 2026, which counts as an intention, not a sale.
Questions about protein concentration, protein type, batch size or minimum order go to the company directly, and the answers should be recorded in the supplier file alongside the grade being evaluated. The homepage also mentions stable supply all year round, a point that can be tested through trial deliveries over several months.
Remilk frames its milk as one example of a wider platform. The mission page describes a food system in which fermentation-derived proteins supply the foundations. A manufacturer interested in the ingredient rather than the retail product should ask whether protein is offered for use in third-party recipes, and under which commercial terms and volumes.
Sustainability claims and how to read them
The gains page gives figures on resource use. It states that production emits up to 97% less greenhouse gases than traditional dairy and needs an estimated 1% of the land, 4% of the feedstock and less than 10% of the water. These are the company’s own estimates, and the page cites no life cycle assessment.
A procurement team that wants to repeat such numbers in marketing should ask for the underlying study, its system boundary and its comparison basis. Fermentation footprints depend heavily on the energy source, the sugar feedstock and whether drying is included. Fermentation results shift with these inputs, so documented methods matter more than any headline percentage.
The company also describes a social responsibility programme called Remilk Cares, covering inclusion and community benefit. This sits outside the technical specification of the protein, but it may matter to buyers who run supplier codes of conduct. The description on the site is general, and a supplier audit would need to confirm what is practised on the production site.
What a buyer would evaluate
The first question for any recombinant dairy protein is regulatory status in the target market. Approval of a fermentation-derived milk protein differs between the United States, the European Union and Israel, and the company’s launch so far is in Israel. A developer planning a product elsewhere should ask for the dossier reference or notification number before fixing a launch date.
Allergen handling comes next. A protein identical to a milk protein is still a milk allergen, even when the finished food contains no cow-derived material, and labels in most jurisdictions must say so. Lactose-free positioning is a separate claim from allergen-free, and the two are easy to confuse in consumer-facing copy, so legal review of pack text is sensible.
Functionality should be tested in the real formulation. Milk proteins behave differently across pH, heat treatment and ionic strength, and a pure protein without the native casein micelle may foam, gel or heat-set differently from milk. Pilot batches, heat stability trials and shelf-life checks show whether the material suits yogurts, cheese analogues or beverages.